Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
In a landmark phase 2 TrialNet study conducted by Herold and colleagues (2019) in at-risk relatives of individuals with T1D, a single 14-day course of Teplizumab delayed the onset of clinical disease by a median of 2 years (hazard ratio = 0.41
Metabolomic changes in the mouse retina after optic nerve injury
Vitamin B2 [2] A micronutrient easily absorbed by the cells in the body
Disclaimer: These statements are for informational purposes only and have not been evaluated by the Food and Drug Administration
US$ 29.12
US$ 21.85
US$ 20.19
US$ 29.08
US$ 29.13
US$ 27.64
US$ 29.68
